| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $34.6M | +36.2% |
| SG&A Expense | $16.6M | +45.2% |
| Operating Income | -$51.2M | -39.0% |
| Net Income | -$37.7M | -23.0% |
| EPS (Basic) | -$1.03 | +61.7% |
| EPS (Diluted) | -$1.03 | +61.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.3M | -54.8% |
| Current Assets | $41.7M | -52.5% |
| Total Assets | $48.4M | -48.4% |
| Current Liabilities | $7.1M | -11.9% |
| Total Liabilities | $12.4M | -48.7% |
| Stockholders' Equity | $36.0M | -48.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$45.9M | -36.2% |
| Investing Cash Flow | -$576K | +76.3% |
| Financing Cash Flow | $55K | -99.9% |